Enlivex Therapeutics Ltd

XNAS:ENLV 4:00:00 PM EDT

1.11

+0.01 (+0.91%)

6:41:57 PM EDT: $1.12 +0.01 (+0.90%)

Enlivex Therapeutics Ltd Stock, XNAS:ENLV

14 Einstein Street, 14 Einstein Street, Ness Ziona, Tel Aviv 7403618

Israel

Phone: +972.8.662.3301

Number of Employees: 49

http://www.enlivex.com

Description

Enlivex Therapeutics Ltd. engages in the development of macrophage reprogramming immunotherapy products. It focuses on the development of Allocetra, a universal off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state. The company was founded by Dror Mevorach on January 22, 2012 and is headquartered in Ness Ziona, Israel.